Medtronic gets FDA approval for Brainsense device in Parkinson's patients
Medtronic said Monday the U.S. Food and Drug Administration has approved a brain-stimulation device as a treatment for people with Parkinson's disease, a major milestone for the technology.
Medtronic said Monday the U.S. Food and Drug Administration has approved a brain-stimulation device as a treatment for people with Parkinson's disease, a major milestone for the technology. 
